Clinical Trials Logo

Clinical Trial Summary

OCTA-guided PDT is as safe and effective as ICGA-guided PDT in the treatment of acute central serous chorioretinopathy. Or OCTA-guided PDT is more effective than ICGA-guided PDT in the treatment of acute central serous chorioretinopathy, safe as well.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03497000
Study type Interventional
Source Peking University People's Hospital
Contact
Status Completed
Phase N/A
Start date September 1, 2017
Completion date March 27, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02681783 - PRedictive Factors and Changes From Treatment in Idiopathic Polypoidal Choroidal Vasuclopathy Versus Central Serous Chorioretinopathy Versus Neovascular Age Related Macular Degeneration With afLibercept Phase 4
Not yet recruiting NCT02215330 - A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy Phase 2/Phase 3
Completed NCT01971190 - Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy Phase 2
Completed NCT01990677 - Eplerenone for the Treatment of Central Serous Chorioretinopathy N/A
Active, not recruiting NCT01710332 - The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy Phase 2
Active, not recruiting NCT00403884 - Selective RPE Laser Treatment (SRT) for Various Macular Diseases N/A
Completed NCT01880788 - Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD N/A
Terminated NCT01982383 - Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy N/A
Completed NCT01327170 - Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy N/A
Completed NCT01019668 - Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy N/A
Recruiting NCT02141308 - OCT in Rare Chorioretinal Diseases
Completed NCT01822561 - Eplerenone for Central Serous Chorioretinopathy Phase 2
Completed NCT00802906 - Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC) N/A
Unknown status NCT00864773 - The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy N/A
Completed NCT00803517 - Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy N/A
Completed NCT00817245 - Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR) Phase 1/Phase 2
Recruiting NCT02815176 - Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers N/A
Recruiting NCT01630863 - The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy N/A
Recruiting NCT02088151 - Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina N/A
Not yet recruiting NCT03542006 - Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy Phase 2